Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals
Vera Portillo, Chiara Fedeli, Pilar Ustero, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 33
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
Jacopo Polvere, Massimiliano Fabbiani, G Pastore, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
Liangyu Kang, Weijing Shang, Peng Gao, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1569-1569
Open Access | Times Cited: 21
Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
Maggie C. Duncan, F. Harrison Omondi, Natalie N. Kinloch, et al.
AIDS (2024) Vol. 38, Iss. 8, pp. 1120-1130
Open Access | Times Cited: 4
A Systematic Review of COVID-19 Vaccine Antibody Responses in People With HIV
Helen Chun, Kyle Milligan, Elfriede Agyemang, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 17
Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
Myrthe L. Verburgh, Lisa van Pul, Marloes Grobben, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 10
Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Living with HIV and Getting Vaccinated: A Narrative Review
Andrea De Vito, Agnese Colpani, Mattia Trunfio, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 896-896
Open Access | Times Cited: 9
Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
Luís F. López‐Cortés, Abraham Saborido-Alconchel, María Trujillo‐Rodríguez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Second and Third Doses, and Influence on Immunovirological Markers
Francesco Maria Fusco, Maria Aurora Carleo, Nadia Sangiovanni, et al.
Viral Immunology (2023) Vol. 36, Iss. 5, pp. 360-365
Closed Access | Times Cited: 8
No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study)
Kendall Kling, Patrick Janulis, Alexis R. Demonbreun, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 7
SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV
Alessandra Vergori, Alessandro Cozzi‐Lepri, Alessandro Tavelli, et al.
International Journal of Infectious Diseases (2024) Vol. 144, pp. 107065-107065
Open Access | Times Cited: 2
Humoral immune response to two doses of COVID‐19 mRNA‐based vaccines in people living with HIV: A systematic review and meta‐analysis
Negin Farhadian, Sara Sharifi, Mahdi Taghadosi, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 5
Advances in Research on COVID-19 Vaccination for People Living with HIV
Junyan Jin, Xiuwen Wang, Raphaël Carapito, et al.
Infectious Diseases & Immunity (2022) Vol. 2, Iss. 4, pp. 213-218
Open Access | Times Cited: 8
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis
Mads Herluf Søndergaard, Jannifer Jasmin Thavarajah, Henry Henson, et al.
HIV Medicine (2023) Vol. 25, Iss. 1, pp. 16-37
Open Access | Times Cited: 4
COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey
Xihong Zhang, Haoting Zhan, Lijing Wang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Immunological and Clinical Responses to Vaccinations among Adults Living with HIV
Carlo Bieńkowski, Zuzanna Żak, Filip Fijołek, et al.
Life (2024) Vol. 14, Iss. 5, pp. 540-540
Open Access | Times Cited: 1
Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
Jin‐Wen Song, Wei Hu, Lili Shen, et al.
Chinese Medical Journal (2022)
Open Access | Times Cited: 6
Double Trouble Co-Infections: Understanding the Correlation Between COVID-19 and HIV Viruses
Sassi Ashraf Ali Abbasi, Tarika Noor, Maneeth Mylavarapu, et al.
Cureus (2023)
Open Access | Times Cited: 3
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients
Monica Basso, Nicole Pirola, Susanna Pascoli, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 82-82
Open Access | Times Cited: 5
Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
Sabrina Manni, Caroline Ruetsch, Roxane Fabre, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients
Natacha Bordry, Anne‐Claire Mamez, Chiara Fedeli, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1284-1284
Open Access | Times Cited: 2
Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study
Irène A. Abela, Anthony Hauser, Magdalena Schwarzmüller, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. e292-e304
Open Access
Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV
Tatjana Baldovin, Davide Leoni, Ruggero Geppini, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1172-1172
Open Access
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy
Jacopo Polvere, Massimiliano Fabbiani, G Pastore, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top